Předměty
Publikace
- Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry2017 | 1. lékařská fakulta
- Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy2016 | Publikace bez příslušnosti k fakultě
- Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression(aEuro)2016 | Publikace bez příslušnosti k fakultě
- Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry2015 | Lékařská fakulta v Plzni, 1. lékařská fakulta
- Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy2015 | Publikace bez příslušnosti k fakultě
- Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry2014 | Fakulta tělesné výchovy a sportu, 1. lékařská fakulta, 2. lékařská fakulta
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial2014 | 2. lékařská fakulta
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen2012 | 2. lékařská fakulta
- EPIC: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer2008 | 2. lékařská fakulta
- Prevence, diagnostika a léčba trombózy spojené se zhoubným nádorem2023 | Lékařská fakulta v Plzni, 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
Loading network view...